Daclizumab Subcutaneous and Hyaluronidase
Determining the interaction of Daclizumab Subcutaneous and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hyaluronidase (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hyaluronidase and immune globulin
- Daclizumab Subcutaneous-Hyaluronidase and rituximab
- Daclizumab Subcutaneous-Hyaluronidase and trastuzumab
- Daclizumab Subcutaneous-Hyaluronidase injection
- Daclizumab Subcutaneous-Hyaluronidase Injection (Human)
- Daclizumab Subcutaneous-Hyaluronidase Subcutaneous, Injection
- Hyaluronidase-Dacogen
- Hyaluronidase-Dacomitinib
- Hyaluronidase-Dactinomycin
- Hyaluronidase-Dactinomycin Injection
- Hyaluronidase-Dactinomycin Intravenous
- Hyaluronidase-Daklinza